Noncommunicable Diseases

Publications

click to view chapters and sections

Disease Control Priorities in Developing Countries (2nd Edition)

1. 47. Alcohol
   1. Burden of Disease Related to High-Risk Alcohol Use
   2. Cost-Effectiveness of Interventions
   3. Economic Benefits of Interventions
   4. Epidemiology of Alcohol Use and Alcohol-Related Disease Conditions
   5. Implementation of Control Strategies: Lessons of Experience
   6. Interventions for Reducing High-Risk Drinking
2. 33. Cardiovascular Disease
   1. Burden of Disease
   2. Conclusions: Pitfalls and Promises
   3. Cost-Effectiveness of Interventions
   4. Epidemiology of CVD
   5. Research and Development
3. 69. Complementary and Alternative Medicine
   1. Demography, Use, Toxicity, and Efficacy
   2. Economics of Complementary and Alternative Medicine and Traditional Medicine
   3. Lessons Learned and Implementation
   4. The Research and Development Agenda
4. 62. Control and Eradication
5. 51. Cost–Effectiveness of Interventions for Musculoskeletal Conditions
   1. Burden of Musculoskeletal Disease
   2. Conclusions: Promises and Pitfalls
   3. Cost-Effectiveness of Interventions for OA
   4. Cost-Effectiveness of Interventions for Other Musculoskeletal Conditions
   5. Cost-Effectiveness of Interventions for RA
   6. Economic Issues
   7. Implementation of Control Strategies: Lessons of Experience
   8. Nature, Causes, and Epidemiology of Musculoskeletal Conditions
   9. Preventive Strategies
   10. Treatments
6. 30. Diabetes: The Pandemic and Potential Solutions
   1. Conclusions
   2. Cost-Effectiveness of Interventions and Priorities
   3. Interventions and Delivery Modes
   4. Lessons and Experience
   5. Nature and Distribution of Diabetes
   6. Research and Development Agenda
7. 36. Diseases of the Kidney and the Urinary System
   1. Causes and Characteristics of the Burden of Diseases
   2. Causes of Diseases of the Kidney and Urinary System
   3. Conclusions: Promises and Pitfalls
   4. Global Perspectives in Relation to RRT
   5. Implementation of Control Strategies: Lessons of Experience
   6. Research and Development Agenda
8. 7. Economic Approaches to Valuing Global Health Research
   1. The Value of Health Research
9. 68. Emergency Medical Services
   1. Burden of Disease
   2. Conclusions: Promises and Pitfalls
   3. Definitions
10. 14. Ethical Issues in Resource Allocation, Research, and New Product Development
    1. Health Resource Allocation
11. 10. Gender Differentials in Health
    1. Antecedents
    2. Conclusions
    3. Cost-Effectiveness of Interventions
    4. Gender Differentials in Disease Burdens
    5. Priority Disease Groups for Women
    6. Research Agenda
    7. Women's Excess Disease Burdens
12. 29. Health Service Interventions for Cancer Control in Developing Countries
    1. Acknowledgments
    2. Applicability of Cost-Effectiveness Studies from Developed to Developing Countries
    3. Burden of Cancer in Developing Countries
    4. Conclusions
    5. Cost-Effectiveness of Cancer Control Interventions
    6. Research Agenda
    7. Types of Interventions for Cancer Control
13. 48. Illicit Opiate Abuse
14. 8. Improving the Health of Populations: Lessons of Experience
15. 40. Interpersonal Violence
    1. Cost-Effectiveness of Interventions
    2. Economic Impact of Violence
16. 2. Intervention Cost–Effectiveness: Overview of Main Messages
    1. Annex 2.A: Intervention Categories and Pertinent Policy Instruments
    2. Annex 2.C: Summary of other Interventions
    3. Discussion
17. 1. Investing in Health
    1. Acknowledgments
    2. Annex 1.A: The Burden of Disease in 2001
    3. HIV/AIDS
    4. Noncommunicable Disease and Injury
    5. Research and Development
    6. The 20th Century Takeoff in Human Health
    7. Why Has Mortality Declined at Such Different Rates in Different Countries?
18. 50. Loss of Vision and Hearing
19. 31. Mental Disorders
    1. Anxiety Disorders
    2. Conclusion: Public Support for a Cost-Effective Intervention Package
    3. Cost-Effectiveness Methods and Results
    4. Mood Disorders
20. 32. Neurological Disorders
    1. Acknowledgments
    2. Cost-Effectiveness of Interventions in Developing Countries
    3. Epilepsy
    4. Missed Opportunities
    5. Parkinson's Disease
    6. Recommendations
    7. Research and Development Agenda
    8. Stroke
21. 60. Occupational Health
    1. Conclusions
    2. Economic Aspects of Intervention
    3. Global Burden of Disease from Occupational Health Risks
    4. Implementation
    5. Nature and Causes of Occupational Health Conditions in the Developing World
    6. Research Agenda
22. 38. Oral and Craniofacial Diseases and Disorders
    1. Acknowledgments
    2. Aspects of Treatment of Cavities and of Caries Disease
    3. Common-Risk-Factor Intervention Programs
    4. Conclusions
    5. Cost-Effectiveness of Oral Health Care
    6. Developmental Disorders
    7. Fluorosis of Teeth
    8. Noma (Cancrum Oris)
    9. Oral Manifestations of HIV/AIDS
    10. Oral Precancer and Cancer
    11. Periodontal Diseases: Chronic Gingivitis and Chronic Periodontitis
    12. Research and Future Actions
23. 52. Pain Control for People with Cancer and AIDS
    1. Burden of Pain from Cancer and AIDS
    2. Conclusions
    3. Implementation of Strategies to Improve Pain Control
    4. Interventions for Pain Relief
    5. Recommendations for Research and Development
24. 44. Prevention of Chronic Disease by Means of Diet and Lifestyle Changes
    1. Chronic Disease Prevention
    2. Conclusions
    3. Cost-Effectiveness of Interventions
    4. Interventions
    5. Research and Development Priorities
25. 4. Priorities for Global Research and Development of Interventions
26. 6. Product Development Priorities
27. 53. Public Health Surveillance: A Tool for Targeting and Monitoring Intervention
    1. Analysis and Dissemination of Surveillance Data
    2. Definitions and Basic Concepts
    3. Future of Surveillance
    4. Research Agenda in Public Health Surveillance
    5. Surveillance for Specific Conditions
28. 35. Respiratory Diseases of Adults
    1. Acute Diseases: Pneumonia and Influenza
    2. Chronic Respiratory Diseases: Nature, Causes, and Burden
    3. Future Research Needs
    4. General Approach to Lowering Risk of Adult Respiratory Disease
    5. Occupational Lung Disease and Other Respiratory Diseases
29. 5. Science and Technology for Disease Control: Past, Present, and Future
    1. Summary
30. 37. Skin Diseases
31. 28. Stunting, Wasting, and Micronutrient Deficiency Disorders
    1. Economic Benefits of Intervention
32. 67. Surgery
    1. Interventions
    2. Nature, Causes, and Burden of Surgical Conditions
    3. Research and Development Agenda
33. 45. The Growing Burden of Risk from High Blood Pressure, Cholesterol, and Bodyweight
    1. Burden of the Disease, Condition, or Risk Factor
    2. Conclusions
    3. Cost-Effectiveness of Interventions
    4. Economic Benefits of Intervention
    5. Epidemiology
    6. Interventions
    7. Research and Development Agenda
34. 46. Tobacco Addiction
    1. Health Consequences of Smoking
    2. Interventions to Reduce Demand for Tobacco
    3. Rationale for Government Intervention
35. 39. Unintentional Injuries
    1. Acknowledgments
    2. Burden and Causes of Unintentional Injuries
    3. Conclusions: Promises and Pitfalls
    4. Costs, Cost-Effectiveness, and Economic Benefits of Intervention
    5. Implementation of Prevention and Control Strategies
    6. Interventions
    7. Research and Development Agenda

Global Burden of Disease and Risk Factors

1. 4. Comparative Quantification of Mortality and Burden of Disease Attributable to Selected Risk Factors
   1. Burden of Disease Attributable to Individual Risk Factors
   2. Burden of Disease Attributable to Multiple Risk Factors
   3. Burden of Disease Attributable to Risk Factors
   4. Directions for Future Research
   5. Discussion
   6. Joint Effects of Multiple Risk Factors
   7. Risk Factor Selection
2. 6. Incorporating Deaths Near the Time of Birth into Estimates of the Global Burden of Disease
   1. The Burden of Disease Resulting from Events Near the Time of Birth
3. 1. Measuring the Global Burden of Disease and Risk Factors, 1990—2001
4. 5. Sensitivity and Uncertainty Analyses for Burden of Disease and Risk Factor Estimates
   1. Acknowledgments
   2. Conclusions
   3. Discounting and Age Weighting in the DALY Measure
   4. Discussion
   5. Sensitivity of Burden of Disease and Injury Results to Variations in Key Parameter Values
   6. Sensitivity of Risk Factor Estimates to Variations in Key Parameter Values
   7. Uncertainty Analysis of the Global Burden of Disease Estimates
   8. Uncertainty Arising from Epidemiological Estimates
   9. Uncertainty Estimates for All-Cause Mortality and Life Expectancies
   10. Uncertainty Estimates for Regional Mortality by Cause
   11. Uncertainty in Disability Weights
   12. Uncertainty in the Disease Burden Attributable to Risk Factors
5. 3. The Burden of Disease and Mortality by Condition: Data, Methods, and Results for 2001
   1. Burden of Disability and Poor Health in 2001
   2. Discussion and Conclusions
   3. Estimating Deaths by Cause: Methods and Data
   4. Global and Regional Mortality in 2001
   5. Global Burden of Disease in 2001
   6. Quantifying the Global Burden of Disease

Priorities in Health

1. 5. Cost–Effective Strategies for Noncommunicable Diseases, Risk Factors, and Behaviors
   1. Alcohol Abuse
   2. Cancer
   3. Cardiovascular Disease, Diabetes, High Blood Pressure, Cholesterol, and Bodyweight
   4. Conclusion
   5. Mental Health
   6. Tobacco Use
   7. Unintentional Injuries
2. 3. Cost–Effectiveness Analysis
   1. How Can Policy Makers Use Cost-Effectiveness Analysis?
   2. What Is Cost-Effectiveness Analysis?
   3. Why Use Cost-Effectiveness Analysis?
3. 8. The Way Forward: A Blueprint for Action

Chapter Presentations

Chapter 01. Investing in Health

1. The Burden of Disease, 2001
2. Preventing and Treating Noncommunicable Diseases: How much health will a million dollars buy?
3. Causes of Death, 2001

Chapter 04. Priorities for Global Research and Development of Interventions

1. Disease Burden Distribution, by Select World Bank Region, 2001
2. Disease Burden Distribution, by Select World Bank Region, 2001

Chapter 47. Alcohol

1. Prevalence of High-Risk Drinking, By Gender, Age, and Region, 2000